Evidence map›Paper›PMID 30962578›Full record

ArticleLeukemia2019

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.

Jinqi Huang, Stepanov Alexey, Jian Li, Terri Jones, Geramie Grande, Lacey Douthit, Jun Xie, Danna Chen, Xiaolei Wu, Maschan Michael and 8 more

Erratum issuedAbstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Advances and Perspectives in the Treatment of T-PLL.Current hematologic malignancy reports · 2020
    Pooled it
  2. Article
  3. Chimeric antigen receptor T cells march into T cell malignancies.Journal of cancer research and clinical oncology · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Jinqi HuangTranslational Medicine Research Center (TMRC), School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
Stepanov AlexeyM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16 /10, Moscow, 117997, Russia.
Jian LiState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
Terri JonesDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Geramie GrandeDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Lacey DouthitDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Jun XieState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
Danna ChenThe Affiliated Hospital of Putian University, Putian, Fujian, China.
Xiaolei WuProteinT Biotechnology Ltd. Co. Tianjin Airport Free Trade Zone, Tianjin, China.
Maschan MichaelDmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Samory Mashela Str. 1, Moscow, 117997, Russia.
Changchun XiaoState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
Jiangning ZhaoDepartment of Hematology, zhongshan Hospital of Xiamen University, Xiamen, 361004, Fujian, China.
Xuehua XieDepartment of Oncology, The first hospital of Putian City, Putian, 351100, Fujian, China.
Jia XieDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Xiao Lei ChenState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China. Cxl2015@xmu.edu.cn.ORCID http://orcid.org/0000-0001-7998-9963
Guo FuState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China. guofu@xmu.edu.cn.
Gabibov AlexanderM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16 /10, Moscow, 117997, Russia. gabibov@mx.ibch.ru.
Chi-Meng TzengTranslational Medicine Research Center (TMRC), School of Pharmaceutical Sciences, Xiamen University, Xiamen, China. cmtzeng@xmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30962578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.